OptumRx - Recall of Limbrel® Products by Primus Pharmaceuticals

Effective January 26, 2018

Author: Erica Lawrence/Friday, February 2, 2018/Categories: APCI Choice

On January 26, 2018, Primus announced a voluntary, user-level recall of all Limbrel products because of rare but serious reversible side effects associated with Limbrel.

The FDA has received 30 adverse event reports of elevated liver function tests or acute hypersensitivity pneumonitis associated with the use of Limbrel products. To date, there have been no deaths reported with the use of Limbrel, and in all reported cases adverse effects resolved without residual effects after discontinuing use of the product.

OptumRx notified members who may be affected by this recall. These members were advised not to use the recalled product, discuss their therapy with their healthcare provider, and to contact Primus for return and refund information. In the future, these members may inquire about the Limbrel prescription(s) you dispensed.

If you have any questions, please call Primus at (480) 483-1410 (9:00 AM – 5:00 PM MT, Monday through Friday) for more information about this recall.

*Please see attached for more information.

Comments are only visible to subscribers.